Charles River Laboratories International's 15min chart shows KDJ Death Cross, bearish Marubozu.

Charles River Laboratories International's 15-minute chart has recently exhibited a bearish trend, as evidenced by a KDJ Death Cross and a Bearish Marubozu on October 7, 2025 at 10:15. This indicates that the momentum of the stock price is shifting towards the downside, potentially leading to further decreases. Sellers appear to be in control of the market, and it is likely that the bearish momentum will continue.

Charles River Laboratories International Inc. (NYSE:CRL) has recently shown signs of a bearish trend on its 15-minute chart, as evidenced by a KDJ Death Cross and a Bearish Marubozu on October 7, 2025, at 10:15 Why Charles River Stock May Struggle In Its Final Phase^[1]. This indicates a shift in the stock's momentum towards the downside, potentially leading to further price decreases. Sellers appear to be in control, suggesting that the bearish momentum may continue.

The stock is currently in Phase 17 of its 18-phase Adhishthana cycle, with Phase 18 set to begin on October 20. Throughout its cycle, Charles River has closely followed the Adhishthana Principles, particularly during Phases 9 to 11. The stock formed a Cakra between Phases 4 and 8 and then broke out in Phase 9, rallying by ~63% before intensifying its move in Phase 10, rising another ~88% Why Charles River Stock May Struggle In Its Final Phase^[1].

However, the stock's outlook for Phase 18 is less optimistic. The preceding three phases, 14, 15, and 16, known as the Guna Triads, exhibited bearish tendencies, ruling out the possibility of a Nirvana move in Phase 18. The absence of Satoguna, or sustained bullish energy, in the triads means that the stock is expected to remain in a prolonged phase of consolidation and sluggishness through Phase 18, which ends in April 2027 Why Charles River Stock May Struggle In Its Final Phase^[1].

Investors looking to buy the stock might prefer to stay patient until stronger structural alignment re-emerges. While short-term rallies may occur in Phase 18, they are unlikely to be sustained. The stock's outlook remains dim, and investors should approach the market with caution.